Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11911222rdf:typepubmed:Citationlld:pubmed
pubmed-article:11911222lifeskim:mentionsumls-concept:C1825588lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C2346452lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C2003888lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C0449864lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C0013778lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C1416611lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:11911222lifeskim:mentionsumls-concept:C0442796lld:lifeskim
pubmed-article:11911222pubmed:issue1lld:pubmed
pubmed-article:11911222pubmed:dateCreated2002-3-25lld:pubmed
pubmed-article:11911222pubmed:abstractTextSelective blockade of the inward rectifier potassium channel I(K1) by barium, or of the rapidly activating delayed rectifier potassium channel I(Kr) by D,L-sotalol, prolongs repolarization and reduces the defibrillation threshold (DFT). This study hypothesized that combination I(K1) and I(Kr) channel block would produce concentration-dependent additive effects on DFT and ventricular refractoriness. A range of barium and D,L-sotalol concentrations, alone and in combination, were examined with respect to DFT, ventricular effective refractory period (VERP), and ventricular fibrillation cycle length (VFCL) in 133 Langendorff-perfused rabbit hearts. Barium produced a concentration-dependent reduction of DFT (-49+/-4%), with concentration-dependent increases in VERP (26+/-6%) and VFCL (42+/-18%). D,L-Sotalol produced a concentration-dependent lowering of DFT (-53+/-6%) with a concentration-dependent increase in VFCL (34+/-8%) but not VERP. Low (1.6 microM), intermediate (3.1 microM), and high (12.5 microM) barium concentrations combined with varying D,L-sotalol concentrations produced equal or smaller decreases in DFT compared with corresponding doses of barium or D,L-sotalol alone. Except at the lowest concentrations of barium (1.6 and 3.1 microM) (p < 0.05), there was no significant additive interaction between barium and D,L-sotalol on VERP or VFCL. Combination I(K1) and I(Kr) channel block by barium and D,L-sotalol does not produce additive reduction of DFT.lld:pubmed
pubmed-article:11911222pubmed:languageenglld:pubmed
pubmed-article:11911222pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:citationSubsetIMlld:pubmed
pubmed-article:11911222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11911222pubmed:statusMEDLINElld:pubmed
pubmed-article:11911222pubmed:monthJanlld:pubmed
pubmed-article:11911222pubmed:issn0008-4212lld:pubmed
pubmed-article:11911222pubmed:authorpubmed-author:QiXiangqianXlld:pubmed
pubmed-article:11911222pubmed:authorpubmed-author:NewmanDavidDlld:pubmed
pubmed-article:11911222pubmed:authorpubmed-author:DorianPaulPlld:pubmed
pubmed-article:11911222pubmed:authorpubmed-author:VarmaPryamvad...lld:pubmed
pubmed-article:11911222pubmed:issnTypePrintlld:pubmed
pubmed-article:11911222pubmed:volume80lld:pubmed
pubmed-article:11911222pubmed:ownerNLMlld:pubmed
pubmed-article:11911222pubmed:authorsCompleteYlld:pubmed
pubmed-article:11911222pubmed:pagination22-30lld:pubmed
pubmed-article:11911222pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:meshHeadingpubmed-meshheading:11911222...lld:pubmed
pubmed-article:11911222pubmed:year2002lld:pubmed
pubmed-article:11911222pubmed:articleTitleCombination IK1 and IKr channel blockade: no additive lowering of the defibrillation threshold.lld:pubmed
pubmed-article:11911222pubmed:affiliationDepartment of Pharmacology, University of Toronto, ON, Canada.lld:pubmed
pubmed-article:11911222pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11911222pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:11911222pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed